When in Rome

The 6th IAS Pathogenesis Conference doesn't really end after the closing session by David Miller In 1987 I attended my first AIDS conference, beginning twenty-four years...

Revisiting Immunity

NAPWA helps to promote immune-based therapies by Chael Needle At the International AIDS Conference last June, the AIDS Institute and the National Association of People with AIDS...

Matters of Survival

Is better HIV treatment related to improved survival after an individual is diagnosed with an AIDS-defining opportunistic illness (AIDS-OI)? That was one of the...

Preventative HIV Vaccine

Express Lane A Vaccine Candidate Seeks to Prevent—Not Just Control—HIV Infection by Chael Needle Preventative HIV vaccine research has taken another step. The candidate, a granulocyte-macrophage colony stimulating factor...

Ending Disparities

As the United States Conference on AIDS (USCA 2015) will convene shortly (September 10–13) in Washington, D.C.—and its theme is “The Numbers Don’t Lie:...

Developing Doravirine

LifeGuide Running Into Options An NNRTI candidate seeks to keep on track to expand therapies by Chael Needle In this next-generation era of anti-HIV meds, research and development...

LATEST POSTS

Bruce Ward: March 2008

Time Differences Playwright Bruce Ward talks with A&U’s Chael Needle about his new play, Lazarus Syndrome, finding support & the need to stay on top...

Edmund White Honored by PEN

Becoming Self-Aware

Edmund White: February 2008